ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Investor Presentation

Gaudium IVF And Women Health Investor Presentation: Key Takeaways

Gaudium IVF reported Q1 FY27 consolidated revenue of Rs. 1,937.66 Lakhs, up 9.13% YoY, while front-loading expansion costs for new hubs and AI integration.

Highlights
Revenue growth9.13% YoY consolidated growth.
MarginsEBITDA margins moderated to 12.51% due to expansion costs.
Demand visibilityStrong; 13.1% India IVF CAGR expected through 2034.
Management confidenceHigh; expanding network to 10 hubs in FY27-28.

Growth

Consolidated revenue grew 9% YoY. Standalone EBITDA and PAT declined 48% and 29% respectively due to aggressive expansion spending.

Outlook

Targeting 10 new hubs by FY28, with two launching soon in Delhi/NCR and Nagpur to drive scale.

Risks

Front-loading of pre-operational expenses and hiring costs led to significant margin compression in the current quarter.

Source

Investor Presentation filed with BSE, NSE: GAUDIUMIVF. Summary written with AI assistance from the document.

Read the document ↗

Gaudium IVF And Women Health Ltd: key numbers

Share price
₹110.29
Market cap
₹802.8 Cr
Revenue (annual)
₹104.4 Cr
Net profit (annual)
₹24.46 Cr
P/E (TTM)
34.7×Sector 46.8×
Promoter holding
71.29%+0.00% QoQ
FII holding
1.19%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Gaudium IVF And Women Health Ltd

All →